Spectrum Pharmaceuticals, Inc.SPPINASDAQ
Loading
| Metric | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +16.76% | +13.09% | +18.27% | +18.46% | +18.96% |
| Weighted Average Shares Diluted Growth | +16.76% | +13.09% | +18.27% | +18.46% | +18.96% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -77.65% | -82.79% | -84.83% | +1224.22% | +5164.16% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -44.11% | -54.62% | -19.53% | -7.36% | +7.62% |
| Book Value per Share Growth | -61.35% | -72.77% | -61.85% | -50.49% | -59.22% |
| Debt Growth | -29.26% | -45.79% | +1915.16% | +2195.40% | +2781.12% |
| R&D Expense Growth | -78.35% | -45.02% | -36.04% | -51.74% | +29.36% |
| SG&A Expenses Growth | -31.05% | -37.25% | -32.51% | -40.19% | +41.82% |